6 program - amazon simple storage service · please note that this program is correct at the time...
TRANSCRIPT
Please note that this program is correct at the time of printing however is subject to change in
the event of unforseen circumstances.
Additional Meetings to be Held at the ANZSN Annual Scienti!c Meeting
Sunday
8 September
Monday
9 September
Tuesday
10 September
Wednesday
11 September
Thursday
12 September
Friday
13 September
ANZSN Council Meeting09:00 – 16:00
Arbour A1
AKTN Meeting07:15 – 08:15
Plaza P8
RACP Advanced Training Meeting07:30 – 09:00
Plaza P8
ANZSIN Interventional Meeting08:20 – 17:30
Arbour A2
Ultrasound for Nephrologists Course08:00 – 17:00
Arbour A1 & A2
Renal Dieticians Symposium10:00 – 16:30
Arbour A2
Renal Scientists Meeting11:00 – 11:30
Plaza P8
ANZSN Renal Scientist Workshop13:30 – 16:30
Plaza P9
ANZSIN Workshop14:00 – 17:00
Plaza P8
ANZSIN AGM17:00 – 17:45
Plaza P7
6
Program
Nephrology and Transplantation Update CoursePlaza Level P6 – P7
Saturday 7 September
Chair: Troy Kay
08:30 – 09:15 Primary hyperaldosteronism Professor Michael Stowasser
09:15 – 10:00 Investigating access failure Dr Mark Ray
10:00 – 10:20 Morning tea
10:20 – 11:05 Lupus Nephritis – an update Professor Hans-Joachim Anders
11:05 – 11:35 ANCA associated vasculitis – an update Dr Shaun Summers
11:35 – 12:05 Renal Histopathology Dr Kimberly Oliver
12:05 – 13:25 Lunch
Chair: Carolyn Clark
13:25 – 14:10 Antibody-mediated rejection Dr Bill Mulley
14:10 – 14:55 Management issues in the chronic allograft recipient Dr Scott Campbell
14:55 – 15:15 Afternoon tea
15:15 – 16:00 CV disease in the CKD patient A/Professor Nicole Isbel
16:00 – 16:30 Nutrition in the CKD patient Dr Katrina Campbell
16:30 – 17:00 PD – what’s new and controversial Professor David Johnson
Course dinner kindly sponsored by Servier
Sunday 8 September
Chair: Sean Kennedy
08:30 – 09:00 AKI biomarkers Professor Zoltan Endre
09:00 – 09:45 AKI dialysis Professor John Kelllum
09:45 – 10:15 Preventing AKI A/Professor Martin Gallagher
10:15 – 10:35 Morning tea
10:35 – 11:20 Tuberous sclerosis Dr Sean Kennedy
11:20 – 11:50 Polycystic kidney Dr Gopi Rangan
11:50 – 12:20 Fabry’s and other unusual diseases – case based Dr Joanna Ghali
12:20 – 13:40 Lunch
Chair: Vincent Lee
13:40 – 14:10 HD – is longer better? Dr Meg Jardine
14:10 – 14:40 Pregnancy and Renal Disease Dr Shilpanjali Jesudason
14:40 – 15:10 AT1 receptor in pre-eclampsia Professor Duska Dragun
15:10 – 15:30 Afternoon tea
15:30 – 16:15 Update in hypertension Professor Vlado Perkovic
16:15 – 16:45 Patient Centred Outcomes Dr Allison Tong
7
Renal Dieticians SymposiumArbour A2
Sponsored by Amgen Australia, Shire Australia, and Nutricia
Sunday 8 September
10:00 Registration, Networking & Refreshments
10:30 – 12:00 Theme Motivational Interviewing
Optimising patient compliance through motivational interviewing
Dr Stan Steindl Psychology Consultants
12:00 – 13:00 Lunch
13:00 – 13:45 Theme Updates in Clinical Practice
The latest evidence in phosphate management A/Professor Carmel Hawley Nephrologist, Princess
Alexandra Hospital
13:45 – 14:30 Dialysis prescription supporting nutrition management Veronica Oliver Nurse Practitioner, Princess
Alexandra Hospital
14:30 – 15:00 Afternoon tea
15:00 – 15:45 Theme Supportive Care and Conservative Management
Shared Decision Making Dr Balaji Hiremagalur Nephrologist, Gold Coast
Hospital
15:45 – 16:30 Conservative management – Multidisciplinary Panel Led by Anthony Meade Senior Dietitian,
Royal Adelaide Hospital
ANZSN Renal Scientists WorkshopPlaza P9
Sunday 8 September
13:30 Welcome
13:40 – 14:10 Analysis of Tissue Injury and Metabolism by Multiphoton Microscopy
Washington Sanchez
14:10 – 14:40 Animal Models of Cardio-Renal Injury Michael Zhang
14:40 –15:10 Role of Uraemic Toxins in Cardiac and Renal Disease: Implications for Cardio-Renal Syndrome
Andrew Kompa
15:10 – 15:30 Afternoon Tea
15:30 – 16:00 Role of miRNAs in Kidney Disease Phillip Kantharidis
16:00 – 16:30 Role of Regulatory T cells in Kidney Disease Stephen Alexander
16:30 Close
8
ANZSN Annual Scienti�c Meeting ProgramBrisbane Convention and Exhibition Centre
Monday 9 September, 2013
08:30 – 09:30 Plenary 1
Plaza Auditorium
Chair: Rowan Walker
Fluids and the kidneyJohn Kellum
09:30 – 10:00 TJ Neale Award 2013
Plaza Auditorium
Chair: Richard Kitching
Alan Cass
10:00 – 10:30 Jacquot Awardees
Plaza Auditorium
Merlin Thomas
Rob Carroll
10:30 – 11:00 Morning Tea in Exhibition Area
11:00 – 13:00 Young Investigator Presentations
Plaza Auditorium
Chair: Toby Coates
11:00 – 11:15 001 | Interleukin 17- Receptor A (IL-17RA) on Leukocytes and Tissue Cells Mediates In!ammation in a Murine Model of Crescentic Glomerulonephritis | Joanna Ghali
11:15 – 11:30 002 | Short and Long Term Biological Variation of High Sensitivity Troponin T (HS-TNT) and N-Terminal B-Type Natriuretic Peptide (NT-PROBNP) in the Stable Dialysis Population | Magid Fahim
11:30 – 11:45 003 | Blocking the NADPH Oxidase NOX4 Activity Provides Renoprotection in Long Term Diabetic Nephropathy | Jay Jha
11:45 – 12:00 004 | E#ect of Sodium Restriction on Blood Pressure, Fluid Status and Proteinuria in CKD Patients: Results of a Randomised Crossover Trial and 6-Month Follow-Up | Emma McMahon
12:00 – 12:15 005 | Blockade of Spleen Tyrosine Kinase (SYK) Inhibits Antibody-Mediated Rejection in Rat Renal Allografts | Sharmila Ramessur
12:15 – 12:30 006 | Calciprotein-Associated Fetuin-A Concentration is Associated With All-Cause Mortality in Patients With Pre-Dialysis CKD | Ed Smith
12:30 – 12:45 007 | CX3CR1-DEC205 DC-Targeted DNA Vaccine Induces Speci$c Antibodies and Limits Atherosclerosis and Macrophage In$ltration in the APO-E Knockout Mouse Model of Atherosclerosis | Jianheng Zhou
12:45 – 13:00 008 | The Bene$ts and Costs of an Acceptable Human Leukocyte Antigen Mismatch Program in Australia | Hung Do Nguyen
13:00 – 14:00 Lunch in Exhibition Area
9
14:00 – 15:30 Haemodialysis: Vascular Access/CKD-MBD
Plaza Auditorium
Chair: Richard Baer and
Nigel Toussaint
CKD: Progression/Glomerulonephritis
Plaza P7
Chair: Peter Kerr and
John Schollum
Experimental Immunology and Developmental Biology
Plaza P6
Chair: Melissa Little and
Carolyn Clark
14:00 – 14:07 009 | The Association Between Glomerular Filtration Rate Estimated by Multiple Methods at Dialysis Commencement and Patient Survival in the Ideal Trial | Muh Geot Wong
021 | Global Longitudinal Strain is Associated With Obesity, In!ammation, Uremic Toxins and Arterial Sti"ness in Patients With Chronic Kidney Disease Stages 3 and 4 | Rathika Krishnasamy
033 | Characterisation of Rare Genetic Polymorphisms and Their Pathogenic Consequences in the Development of Systemic Lupus Erythematosus | Simon Jiang
14:07 – 14:14 010 | The Slo-Niacin Trial: A Double-Blind Placebo Controlled Randomised Cross-Over Trial of Low Dose Slow-Release Niacin to Lower Phosphate in Haemodialysis Patients | Ken-soon Tan
022 | The Association Between Quality of Life and Global Longitudinal Strain in Patients With Chronic Kidney Disease Stages 3 and 4 | Rathika Krishnasamy
034 | Inhibition of IL-6 Receptor Attenuates Autoimmunity and Glomerulonephritis in Experimental ANCA Vasculitis | Sharon Ford
14:14 – 14:21 011 | Buttonhole Cannulation and Infection Outcomes: Systematic Review and Meta-Analysis | Sradha Kotwal
023 | Oxidative Stress is Associated With Poor Grip Strength and Sarcopenia in Patients With Chronic Kidney Disease | Kassia Weston
035 | Glomerular Deposition of Myeloperoxidase and NETs Correlate With the Presence of Delayed Type Hypersensitivity E"ector Cells in ANCA Vasculitis | Stephen Holdsworth
14:21 – 14:28 012 | Utility of “Back Up” Arterio-Venous Fistulas in Patients on Peritoneal Dialysis and Use of Central Lines: A Comparison Between Two Australian Centres | Nitesh Rao
024 | AST-120 (Kremezin) for Delaying Progression in Patients With Chronic Kidney Disease: A Systematic Review | Kristine Gapuz
036 | An Integrated Cell, Tissue and Whole Organ Pro#le of Kidney Morphogenesis | Alexander Combes
14:28 – 14:35 013 | Fetuin-Containing Calciprotein Particle Levels Can Be Reduced by Dialysis, Sodium Thiosulphate and Plasma Exchange. Potential Therapeutic Implications | Michael Cai
025 | Kidney Disease Knowledge Among New Patients Referred to a Hospital Nephrology Outpatient Department – 1 Year Follow-Up | Jola Kapojos
037 | Kidney CD103+ DCS Exacerbate Renal Injury Through Activating CD8+ T Cells in Adriamycin Nephropathy | Qi Cao
14:35 – 14:42 014 | Use of Stents in Haemodialysis Fistulae: Success and Long Term Follow-Up | Brendon Neuen
026 | Nutritional Status is Associated With the Future Treatment Choice – Renal Replacement Therapy vs. Conservative Care in End Stage Kidney Disease Patients Attending the Multidisciplinary Pre-Dialysis Assessment Clinic | Maria Chan
038 | Selective Epithelial Potential of a Renal Mesenchymal Stem Cell-Like Population Derived From Mature Collecting Duct Epithelium | Joan Li
10
Haemodialysis: Vascular Access/CKD-MBDContinued
CKD: Progression/GlomerulonephritisContinued
Experimental Immunology and Developmental BiologyContinued
14:42 – 14:49 015 | Upper Arm Fistulae and Multiple Stenoses In�uence Haemodialysis Arteriovenous Fistulae Patency After Balloon Angioplasty? | Brendon Neuen
027 | Uremic Toxins and In�ammation in Chronic Kidney Disease | Katrina Campbell
039 | FMS-Like Tyrosine Kinase 3 Ligand (FLT3-L) Induces Regulatory T Cells (TREGS), But Does Not Protect Mice From Experimental Crescentic Glomerulonephritis (GN) | Joanna Ghali
14:49 – 14:56 016 | Clinical Outcomes After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease | Mardiana Lee
029 | “I Don’t Like What I Read About Chronic Kidney Disease, I Might as Well Just Go Get a Gun and Shoot Myself”: Focus Group Study of Patients With Early Stage Chronic Kidney Disease | Pamela A Lopez-Vargas
040 | Loss of CRIM1 Results in Renal Papillary Hypoplasia via Perturbations to WNT/β-Catenin Signalling | Yu Leng Phua
14:56 – 15:03 017 | Outcome of Predialysis Education in Western Sydney: Early Referral is Associated With Reduced Rate of Line Use at First Dialysis | Tatiana Smolonogov
030 | Improved Patient Access to Dietetic Services in Chronic Kidney Disease Using a Categorised Referral Tool | Belinda Mason
041 | Innate Immune Cells Produce Interleukin-17A, Which Drives Autoimmunity and Lupus Nephritis | Shaun Summers
15:03 – 15:10 018 | Factors In�uencing Haemodialysis Arteriovenous Fistula Patency After Balloon Angioplasty; a Systematic Review | Brendon Neuen
031 | Idiopathic Membranous Nephropathy (IMN) Treatment and Outcomes: A Retrospective Case Review Study | Danielle Wu
042 | Increased Tubulointerstitial Recruitment of Human CD141hi CLEC9A+ and CD1C+ Myeloid Dendritic Cells in Fibrotic Kidney Disease | Ray Wilkinson
15:10 – 15:17 019 | Improving Vascular Access Outcomes at Gold Coast | Samuel Thokala
032 | Alport Syndrome and Thin Basement Membrane Nephropathy in the Queensland Chronic Kidney Disease (CKD) Registry | Andrew Mallett
043 | Directing the Di"erentiation of Human ES Cells Towards a Renal Fate | Minoru Takasato
15:17 – 15:24 020 | Serum Gentamicin Monitoring is Not Warranted With Use of Gentamicin Citrate Lock for Central Venous Dialysis Catheters (CVC) | Jo Ryan
044 | Female Mice O"spring Are More Susceptible to Kidney Underdevelopment and Decline in Kidney Function Than Male O"spring Due to Maternal Cigarette Smoke Exposure During Gestation and Lactation | Ibrahim Al-Odat
15:24 – 15:31 045 | Interleukin-12 and 18 Stimulated T Cells in Uraemic Serum Reduce Production of Interferon-Gamma and Proliferation in Vitro | Morgan Mannion
15:30 – 16:00 Afternoon Tea in Exhibition Area
11
16:00 – 17:30 KHA Award Presentations
Plaza Auditorium
Chair: Kevan Polkinghorne
Seminar 1 : Basic Science: Immune Pathology and Disease
Plaza P6
Chair: Shaun Summers
How the NLRP3 in�ammasome triggers renal immunopathology | Hans-Joachim Anders
Cellular immunity in renal vasculitis – what do we know now | Richard Kitching
Oxidative stress biomarkers in kidney disease | Je! Coombes
16:00 – 16:15 046 | New Zealand Survey of Glomerulonephritis | Caroline Lunda Chembo
16:15 – 16:30 047 | Outcomes of Cardiac Surgery in Chronic Kidney Disease | Mangalee Fernando
16:30 – 16:45 048 | Exercise and Lifestyle Intervention in Chronic Kidney Disease: E!ects on Cardiovascular Function | Nicole Isbel
16:45 – 17:00 049 | A Randomised, Controlled Trial of Exit Site Application of Medihoney for the Prevention of Catheter-Associated Infections in PD Patients – Honeypot Study | David Johnson
17:00 – 17:15 050 | Global Longitudinal Strain is an Independent Predictor of All-Cause and Cardiovascular Mortality in Patients With Advanced Chronic Kidney Disease | Rathika Krishnasamy
17:15 – 17:30 051 | Comparison of Estimated Glomerular Filtration Rate by the CKD-EPI Equations With and Without Cystatin C for Predicting Cardiovascular Mortality in Elderly Women | Wai Lim
17:30 – 18:30 ANZSN Annual General Meeting
Plaza Auditorium
18:30 – 20:30 Welcome Reception in Exhibition Area*
*Commencing at the conclusion of the AGM
Tuesday 10 September, 2013
08:30 – 09:30 Plenary 2
Plaza AuditoriumChair: Toby Coates
Receptor Antibodies between Allo- and Autoimmunity | Duska Dragun
09:30 – 11:00 ANZDATA Session
Plaza AuditoriumChair: Steven Chadban
Seminar 2 : Basic Science
Plaza P6Chair: Glenda Globe
Looking to the Future: Emerging Technologies | Michael Hickey | Melissa Little | Matt Sweet
11:00 – 11:30 Morning Tea in Exhibition Area
11:30 – 13:00 Haemodialysis: Outcomes
Plaza AuditoriumChair: Nicholas Gray and Meg Jardine
Epidemiology and Public Health
Plaza P7Chair: Martin Gallagher and Magid Fahim
Experimental Tubulointerstitial Disease 1
Plaza P6Chair: David Nikolic-Paterson and Linda Gallo
11:30 – 11:37 052 | The Impact of Haemodia"ltration, Haemo"ltration and Haemodialysis on Clinical Outcomes: A Systematic Review and Meta-Analysis | Amanda Wang
064 | Early Versus Late Referral to Specialist Nephrology Services – a Systematic Review | Maleeka Ladhani
076 | Vascular Dysfunction in Albuminuria: Role of Endothelial Glycocalyx Disruption | Andy Salmon
12
Haemodialysis: OutcomesContinued
Epidemiology and Public HealthContinued
Experimental Tubulointerstitial Disease 1Continued
11:37 – 11:44 053 | Gender Di�erences in Treatment Patterns of End-Stage Kidney Disease in Indigenous Australians | Charlotte McKercher
065 | An Australian Scored Salt Questionnaire: Development and Validation in Chronic Kidney Disease | Belinda Mason
077 | Identi!cation of a Novel Pathway Promoting Salt-Retention in Obesity | Matthew Davies
11:44 – 11:51 054 | Gender Di�erences in Treatment Patterns of End-Stage Kidney Disease in Non-Indigenous Australians | Charlotte McKercher
066 | Chronic Kidney Disease and Risk of Stroke: A Systematic Review and Meta-Analysis | Philip Masson
078 | Resolvin D1 Protects Podocytes in Adriamycin-Induced Nephropathy Through Modulation of 14-3-3β Acetylation | Jinhua Li
11:51 – 11:58 055 | Outcomes in Rural Versus Urban End Stage Kidney Disease in New South Wales Using Data Linkage | Sradha Kotwal
067 | Association Between Flavonoid Intake, Renal Function and Renal Outcomes in Elderly Women | Wai Lim
079 | Curcumin Attenuates Growth of Established Renal Cell Carcinoma Through Suppression of Nuclear Factor-Kappa B | Christudas Morais
11:58 – 12:05 056 | Renal Replacement Therapy (RRT) in Systemic Lupus Erythematosus (SLE) Patients in Australia and New Zealand | Deborah Perkins
068 | Retinal Arteriolar Narrowing Correlates With Mean Systolic Waking BP and LVH | Judy Savige
080 | A Head to Head Comparison of the Anti-Fibrotic Properties of Relaxin and Enalapril in Experimental Cardiac and Renal Fibrosis | Tim Hewitson
12:05 – 12:12 057 | Pregnancy Outcomes According to Dialysis Commencing Before Or After Conception in Women With End-Stage Kidney Disease | Shilpa Jesudason
069 | Relationship Between Urinary Phosphate With Cardiovascular Disease and Mortality in the Ausdiab Cohort | Nigel Toussaint
081 | Apoptosis Signal-Regulating Kinase 1 (ASK1) Promotes Renal Fibrosis and Apoptosis in the Obstructed Kidney | Frank Yuanfang Ma
12:12 – 12:19 058 | A Cross-Sectional Descriptive Study of Palliative Care Outcome Scale-Symptoms (POS-S-Renal) Reported by Haemodialysis Patients and Sta� | Thida M Myint
070 | Chronic Kidney Disease (CKD) Patient Outcomes: A Longitudinal Report From the CKD.QLD Registry | Anne Salisbury
082 | Relaxin Inherently Requires the Angiotensin II Type 2 Receptor to Abrogate Renal Fibrosis | Bryna Chow
12:19 – 12:26 059 | Renal Replacement Therapy Due to Lithium Toxicity in Australia | Blair Grace
071 | Prevalance of Sarcopenic Obesity and Relationship With In#ammation in Chronic Kidney Disease | Eryn Murray
083 | Blockade of Angiotensin II Type I Receptor (AT1) and CC Chemokine Receptor 2 (CCR2) Heteromers in Progressive Chronic Kidney Disease | Yuan Zhang
12:26 – 12:33 060 | Predicting Dialysis Start Date – the Christchurch Experience | Andrew McNally
072 | Key to Good Health: Assessing the E�ectiveness of Community Screening for Chronic Kidney Disease | Marie Ludlow
084 | KCA3.1 Mediates Renal In#ammation in Mouse Models of Diabetic Nephropathy | Chunling Huang
13
Haemodialysis: OutcomesContinued
Epidemiology and Public HealthContinued
Experimental Tubulointerstitial Disease 1Continued
12:33 – 12:40 061 | Benchmarking Prevalence of Malnutrition Across Queensland Dialysis Units | Simone Venning
073 | A Pragmatic Trial of a Polypill-Based Strategy to Improve Adherence to Indicated Preventive Treatments Among People at High Cvd Risk | Alan Cass
085 | The Pathogenic Role of TXNIP in the Development of Tubulointerstitial Fibrosis in Diabetic Nephropathy – Opportunities for New Therapies | Christina Tan
12:40 – 12:47 062 | What is Haemodynamic Stability? The Importance of ‘Time’ in ‘Change Over Time’ | Scott Wilson
074 | Chronic Kidney Disease (CKD) is Not Renal Replacement Therapy (RRT): the CKD.QLD Registry Dataset | Helen Healy
086 | Long-Term Modulation of Lithium-Induced Nephrogenic Diabetes Insipidus by Amiloride | Priyakshi Kalita
12:47 – 12:54 063 | A Novel Method to Pro!le the Cardiovascular Stability of Dialysis Patients by Continuous Measurement Using a Median Hybrid Preprocessing Filter Algorithm | Scott Wilson
075 | Evaluating the Characteristics of Newly Diagnosed Renal Cell Carcinoma to Improve Patient Outcome | Ning Yap
087 | Pyrrolidine Dithiocarbamate Attenuates Kidney Enlargement in Experimental Polycystic Kidney Disease | Michelle Ta
12:54 – 13:01 088 | Numbers of Podocytes and Parietal Epithelial Cells in the Normal Human Kidney: Associations With Glomerular Size | Victor Puelles
13:00 – 14:00 Lunch in Exhibition Area
14:00 – 15:30 Basic Science Award
Plaza P6
Chair: Tim Hewitson and Josephine Forbes
Seminar 3 : Clinical Science Session
Plaza Auditorium
Chair: David Mudge
Design of AKI biomarker trials (AKI Trial) | John Kellum
Cochrane Group | Jonathan Craig, Sally Green
14:00 – 14:15 089 | γδ T Cells Are Essential for the Development of MPO Autoimmunity and Glomerulonephritis | Poh Yi Gan
14:15 – 14:30 090 | Systemic Overexpression of Endogenous Secretory Rage (ESRAGE) Attenuates Diabetic Kidney Injury in Mice | Huiling Wu
14:30 – 14:45 091 | Macrophage-Myo!broblast Transition – a Mechanism Contributing to Myo!broblast Accumulation in Human and Experimental Renal Fibrosis | David Nikolic-Paterson
14:45 – 15:00 092 | A Functional Role for Spleen Tyrosine Kinase (SYK) in In!ltrating Myeloid Cells in Human and Experimental Acute Glomerular Disease | Jessica Ryan
15:00 – 15:15 093 | How Missense Mutations in the COL4A5 Gene Cause Alport Syndrome | Judy Savige
15:15 – 15:30 094 | Interleukin 17A Drives Acute Kidney Injury Through the Recruitment of Innate E$ector Cells | Shaun Summers
15:30 – 15:45 Session Change Over
14
15:45 – 16:51 Home DialysisPlaza AuditoriumChair: Carolyn Van Eps and John Agar
AKI/Drugs in CKDPlaza P7Chair: Murray Leikis and Victoria Campbell
Transplantation 1Plaza P6Chair: Katherine Barraclough and Scott Campbell
15:45 – 16:02 095 | Socio-Economic Disparities in the Uptake of Home Dialysis | Blair Grace
103 | Plasma Cystatin C is Elevated in the Absence of Acute Kidney Injury Following Cisplatin With Contemporary Antiemetics | Timothy Pianta
110 | Survival After Cutaneous Melanoma in Kidney Transplant Recipients: A National Population-Based Matched Cohort Study | Patrick Kelly
16:02 – 16:09 096 | Fetuin-A-Containing Calciprotein Particles in Peritoneal Dialysis Fluid | Ed Smith
104 | Ace Inhibitor Use and AKI Outcomes: An Analysis of the Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy (Renal) Trial | Amanda Wang
111 | Long-Term Outcomes Following Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis | Philip Clayton
16:09 – 16:16 097 | Lifestyle, Sexual Function and Peritoneal Dialysis | Matthew Sypek
105 | Diagnostic Test Levels of Urine Interleukin-18 as an Early Biomarker of Acute Kidney Injury (AKI) in ICU at Muhammad Hoesin Hospital Palembang | Novadian Suhaimi Husin
112 | Urinary Clusterin Predicts Graft Recovery Within Four Hours of Kidney Transplantation | Timothy Pianta
16:16 – 16:23 098 | Psychological Factors Associated With Successful Outcomes in Home Haemodialysis | Jane Nearhos
106 | The Incidence of Acute Kidney Injury Associated With Broad-Spectrum Antibiotics | Kathryn Ducharlet
113 | Living Kidney Donor Assessment: The Challenges, Uncertainties and Controversies Among 110 Transplant Nephrologists and Surgeons From 12 Countries | Allison Tong
16:23 – 16:30 099 | End-Stage Kidney Disease – Supporting the Treatment Option Decision Making Process | Debbie Fortnum
107 | Drug Dosing in the Elderly: The Impact of Age and Tubular Function | Tracey Putt
114 | The Bene!ts and Costs of Luminex Testing for Preformed Antibodies in Renal Transplantation | Hung Do Nguyen
16:30 – 16:37 100 | Introducing Nxstage Haemodialysis in the Australian Home | Carolyn Van Eps
108 | Acute Kidney Injury, Analgesic Nephropathy and Toxin-Mediated Kidney Injury in an Australian Chronic Kidney Disease (CKD) Cohort | Andrew Mallett
115 | The Impact of Diabetes Mellitus on Arterial Sti"ness After Transplantation | Andrea Viecelli
16:37 – 16:44 101 | Barriers to Home Dialysis Therapies | Annabel Martin
109 | A Justi!cation for Less Restrictive Guidelines on the Use of Metformin in Renal Failure | William Adam
116 | Glycaemic Pro!le Early After Kidney Transplantation: Highs, Lows and Diagnostic Dilemmas | Philip Clayton
16:44 – 16:51 102 | eGFR-Based Comparison of Dialysis Adequacy Between Nocturnal Home-Based and Conventional Facility-Based Haemodialysis | Hasan Al-Khayyat
117 | Conversion From Calcineurin-Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomised Trials | Wai Lim
16:50 – 18:00 Poster Session with Drinks and Nibbles in Exhibition Area
19:00 – 23:30 ANZSN ASM Dinner Transfers to dinner departing Brisbane Convention & Exhibition Centre
15
Wednesday 11 September, 2013
09:00 – 09:30 Seminar 4
Plaza AuditoriumChair: Mark Marshall
Chronic Humoral Rejection | Duska Dragun
09:30 – 10:00 Seminar 5
Plaza AuditoriumChair: Richard Baer
Integrated Care in CKD | Miguel Riella
10:00 – 11:00 Plenary 3
Plaza AuditoriumChair: Gopala Rangan
Danger Control – Understanding Kidney Pathology | Hans-Joachim Anders
11:00 – 11:30 Morning Tea in Exhibition Area
11:30 – 13:00 Indigenous Populations/ADPKD/Other
Plaza AuditoriumChair: Matthew Jose and Murty Mantha
Transplantation 2
Plaza P7
Chair: Nicole Isbel and Wai Lim
Experimental Tubulointerstitial Disease 2
Plaza P6
Chair: John Leader and
Lorine Wilkinson
11:30 – 11:37 119 | Lifetime Risk for End Stage Renal Disease in a Remote Aboriginal Community: E!ect of Diabetes | Zhiqiang Wang
130 | Patients’ Attitudes Towards Living Kidney Donation: Systematic Review and Thematic Synthesis of Qualitative Research | Camilla Hanson
142 | VEGF165b is Protective in Diabetic Nephropathy | Andy Salmon
11:37 – 11:42 120 | Quantitative Analysis of Total Kidney Volume in Adpkd Using 3D Slicer | Jun Mai
131 | Value of 3- and 12-Month Surveillance Renal Transplant Biopsy: A Single Centre 5-Year Study | Peggy Teh
143 | Glyoxalase-1 Inhibition Leads to Diabetic Kidney Disease Associated With Podocyte Insulin Resistance | Linda Gallo
11:42 – 11:49 121 | Trends in Health Status and Chronic Disease Risk Factors Over 10-14 Years in a Remote Australian Aboriginal Community: A Matched Pair Study | Zaimin Wang
132 | Public Awareness and Attitudes to Living Organ Donation: Systematic Review and Integrative Synthesis | Allison Tong
144 | Semicarbazide-Sensitive Amine Oxidase Inhibitor Inhibits Extracellular Matrix Deposition in Kidney Fibrosis | May Wong
11:49 – 11:56 122 | Screening and Staging of Chronic Kidney Disease: An Audit in Aboriginal People of the Gove Region in 2011-2 | Mani Berghout
133 | Racial Variation in Paediatric Transplant Outcomes | Blair Grace
145 | Notch Signaling Mediates MMP-9-Dependent Endothelial- Mesenchymal Transition Dowstream of TGF-β in Human Renal Glomerular Endothelial Cells | Ye Zhao
11:56 – 12:03 123 | Incidence and Clinical Syndrome of IGG4-Related Tubulointerstitial Nephritis in 2 Tertiary Hospitals in South Western Sydney | Kathy Mac
134 | Preferred Outcomes Following Immunosupression Among Kidney Transplant Recipients | Martin Howell
146 | Adenine-Induced Chronic Kidney Disease is Associated With Arterial Macrophage In#ltration and Medial Vascular Calci#cation | Jianheng Zhou
16
Indigenous Populations/ADPKD/OtherContinued
Transplantation 2Continued
Experimental Tubulointerstitial Disease 2Continued
12:03 – 12:10 124 | A Comparison of PBS Medications in Two Remote Central Australian Aboriginal Communities | Wendy Hoy
135 | Obesity as a Barrier to Renal Transplantation: A Multidisciplinary Weight Loss Study | Sarah Jukes
147 | Early Intervention With Apyrase Ameliorates Fibrosis After Unilateral Ischemia Reperfusion Injury (IRI) | Veena Roberts
12:10 – 12:17 125 | The Relationship Between Body Build, Composition and Kidney Damage in Aboriginal and Torres Strait Islander Peoples | Jaquelyne Hughes
136 | South Australian and Northern Territory Indigenous Transplant Outcomes, 2001-2011 | Michael Burke
148 | Peroxisome Proliferator Activated Receptor-Y Activation Does Not Protect Human Kidney Proximal Tubular Epithelial Cells Against Oxidative Stress | David Small
12:17 – 12:24 126 | Molecular Characteristics of Renal Cell Carcinoma – a Study Using TRAF-1 and a Malaysian Patient Cohort | Retnagowri Rajandram
137 | Outcomes of Tasmanian Living Kidney Donors | Isobelle Smith
149 | Inhibition of Tubular Albumin Degradation is a Common Feature in Proteinuric Disease Models | Greg Tesch
12:24 – 12:31 127 | Survey of Renal Training in Metropolitan Vs Non Metropolitan Areas | Shenaaz Mazid
138 | Living Donor Kidney Transplantation: A Comparison Between Pre-Emptive and Dialysis-Dependent Patients | Nigel Toussaint
150 | The Role of Toll-Like Receptor Proteins (TLR) 2 and 4 in Mediating In!ammation in Human Microvascular Endothelial Cells (HMEC-1) | Harshini Mudaliar
12:31 – 12:38 128 | Audit Comparing Ultrasound Guided Percutaneous Native Kidney Biopsy Performed by Interventional Radiolosist With Those Performed by Nephrologists and Nephrology Trainees | Sajed Valappil
139 | How Well Do We Follow-Up Living Kidney Donors? | Isobelle Smith
151 | The PDE4 Inhibitor Ro!umilast Reduces TGF-β Induced Pro-Fibrotic and Proliferative E#ects in Vitro | Xianzhong Lau
12:38 – 12:45 129 | Autosomal Dominant Polycystic Kidney Disease in an Australian Chronic Kidney Disease (CKD) Population | Andrew Mallett
140 | High Prevalence of De Novo Hla Antibodies Post Transfusion in Renal Transplantation | Ubaidullah Dawood
152 | Urinary Biomarker KIM-1 Rises Earlier Than Ngal in Experimental Aristolochic Acid Nephropathy | Lena Succar
12:45 – 12:52 141 | Angiotensin 2 Type 1 Receptor Activating Antibodies in Transplant Glomerulopathy | William Hanf
13:00 – 14:00 Lunch in Exhibition Area
Meeting End
17
18
Posters
Transplantation
153 | Correlation of Serum Creatinine at Day 14 and 180 Post Renal Transplant with Allograft Kidney Volume Measured Radiologically | Keng Lim Ng
154 | Low Titre Donor Speci!c Antibodies are Associated with a High Risk of Antibody Mediated Rejection | Matthew Sypek
155 | The Associations Between 25-OH Vitamin D (25-OHD) and Clinical Outcomes in Renal Transplant Recipients (RTR) | Matthew Damasiewicz
156 | Latent Tuberculosis: Testing and Risk Factor Assessment in Potential Kidney Transplant Recipients | Thomas Rogerson
157 | Use of Metformin for Treatment of New Onset Diabetes After Transplantation (NODAT) | Surjit Tarafdar
158 | Outcomes of a Unit-Wide Policy of Prophylaxis Against Pneumocystis Jirovecii Pneumonia (PCP) in Prevalent Kidney Transplant Recipients (KTR) | Gerard Olive
159 | CNI-to-Everolimus Conversion in Renal Transplant Rrecipients with Low Immunological Risk: Improved or Maintained GFR after 2.5 years | Hilton Gock
160 | Management of Kidney Transplant Recipients (Ktr) at a Single Centre in the Context of Recent Guideline Publication | Carolyn Clark
161 | High-Sensitivity Troponin T as a Predictor of Cardiovascular Morbidity in Renal Transplant Receipients | Karen Fernandez
162 | An Audit of Pre-Transplant Co-Morbity and Short-Term Outcome in Diabetic Kidney Transplant Recipients at a Single Transplant Centre | John Whitlam
Experimental Tubulointerstitial Disease
163 | Renoprotection with SGLT2 Inhibition | Chunling Huang
164 | Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes | Aowen Zhuang
165 | Renal Fibrosis Following Renal Ischemia Reperfusion Injury (IRI) Is Exacerbated in the Presence of a Normal Kidney | Veena Roberts
166 | Amiloride Modi!es Renal Fibrosis Induced by Long Term Lithium Treatment | Priyakshi Kalita
167 | Maternal Obesity Is Associated with Changes in Gene Expression of In"ammatory Cytokines in the Kidney of Rat O#spring | Muh-Geot Wong
Experimental Immunology & Developmental Biology
168 | Intrauterine Hypoxia Impairs Kidney Development Via Disruption to β-Catenin Activity | Lorine Wilkinson
169 | Human Kidney Proximal Tubule Epithelial Cells (Ptec) Modulate Autologous Immune Responses by Contact Dependent Mechanisms | Sandeep Sampangi
170 | Reduced Nephron Number But Hypotension in Male Mouse O#spring Following Prenatal Corticosterone Exposure | Reetu Singh
171 | Chronic Mid-Late Gestational Hypoxia Alters Renal Structure and Function in Adult Male Mouse O#spring | Sarah Walton
19
172 | Periconceptional Ethanol Exposure in the Rat Alters Kidney Development with Functional Changes in Adult Male O�spring | Emily Dorey
173 | Midkine Antibodies Prevent Renal Injury in Adriamycin Nephropathy | Yiping Wang
174 | The Role of β-Catenin IN TGF-β1-Induced FOXP3 Expression and TREG Induction | Yun Zhang
175 | Maternal Hypomagnesaemia Causes Foetal Growth Restriction But Does Not Alter Renal Morphology Or Mangesium Channel Expression in O�spring | Richard Schlegel
176 | Elevated Concentrations of Interleukin-12 and 18 in Chronic Kidney Disease Patients Synergistically Induce T-Cell Activation and Proliferation in Vitro | Morgan Mannion
177 | Analysis of Linkage of P2X7R to BALB/C Associated Kidney Injury in the Adriamycin Murine Model in F2 Mice | Yuan Min WANG
CKD
178 | Survey of Current Renal Trainee’s Attitude to Interventional Nephrology | Shenaaz Mazid
179 | Cost E!ectiveness of Urine Protein Screening on Di!erent Population | Artaria Tjempakasari
180 | CKD Patient Pro"les from a Regional Queensland Health Renal Clinic and Outcomes After One Year. CKD.QLD Registry | Anne Salisbury
181 | The Lupus Nephritis Australian Registry (LUNAR) | Richard Phoon
182 | Assessment of Cadmium Load in Renal Biopsies from Sri Lankan People with Chronic Kidney Disease of Unknown Origin | Susan Mott
183 | Prevalence and Composition of Urinary Tract Stones from a Tertiary Care Hospital, Riyadh | Noura Al-Jameil
184 | Recognising Salt Wasting Nephropathy | Peter McClelland
185 | The Development and Growth of CKD.QLD: A Four Year Journey | Sree Krishna Venuthurupalli
186 | Tele-Video Consultations: a Useful Adjunct for Regional Nephrology? | Martin Knapp
187 | Immuno#uorescence Study of Renal Biopsies in Nepal | Gayatri Das
188 | Is the Presence of Positive ANCA Assay Su$cient to Preclude the Need for a Renal Biopsy? | Pooja Sanghi
189 | Histopathology Classi"cation of Lupus Nephritis Kidney Biopsy in Semarang – Indonesia | Ita Murbani Handajaningrum
190 | Kidney Biopsy Histopathology in Semarang, Indonesia | Ayudyah Nurani
Dialysis
191 | Haemoglobin Variability as a Result of In#ammation in Haemodialysis Patients | Ali Al-Baldawi
192 | Management of Hyperphosphatemia in Haemodialysis Patients in an Outer Metropolitan Dialysis Unit: The Operation Phosphate Aggressive Lowering (OPAL) Project | Hemant Kulkarni
193 | Early Experience with Placement of Tenckho! Peritoneal Dialysis Catheters Using the Modi"ed Seldinger Technique | Arjuna Marasinghe
194 | Nutritional Status and Adequacy of Haemodialysis | Achmad Taruna
195 | Analysis of the Cost-E!ectiveness of Switching from Sevelamer Hydrochloride to Lanthanum Carbonate Monotherapy: Applications For Australian Costs | Rebecca Agnew
196 | The Placement of Tenckho! Catheter For CAPD with Bandung Method | Jonny Jonny
197 | Every Day Is a New Day : The Cardiovascular Response to Standard In-Centre Haemodialysis (HD) Is Not Consistent Across Serial Treatments | Scott Wilson
198 | Emerging Patterns in Blood Pressure and Volume in The Incident Dialysis Period: The In#uence of Primary Renal Disease | Michelle Lewicki
20
199 | Investigating Barriers to E�ective Predialysis Planning of Paci�c Islander Patients in Western Sydney | Yasith Kamaladasa
200 | Microbiological Pro�le of Blood Culture Positive Bacteremia in CKD V Patients Undergoing Haemoadialysis and Clinical Outcomes | Arjuna Marasinghe
201 | Hand Grip Strength as a Marker of Malnutrition in Haemodialysis Patients | Nikki Levitas
202 | Consider – Considerations of Nephrologists When Suggesting Dialysis in Elderly Patients with Renal Failure | Celine Foote
203 | Balloon Assisted Maturation (BAM) of Arteriovenous Access Performed by Australian Nephrologists: A Single Centre Case Series | Richard Baer
204 | Foodservice Satisfaction in Dialysis Patients on Renal Diets During Previous Hospital Admissions Is Lower Than General Medical and Surgical Inpatients | Sally Noble
205 | Line Use at First Dialysis, Is this a Valid Key Performance Indicator? | Chenlei Li
206 | Mucocutaneous Manifestations of Chronic Kidney Disease Patients on Hemodialysis | Gayatri Das
207 | Interventional Nephrology Program in Maintaining Patency in Dysfunctional Access in Remote Central Australian Renal Patients | David Fernandes
208 | Cu�ed and Tunnelled Vascular Access for Haemodialysis: A Single Centre Experience | Md Shahadat Hossain
209 | Adequacy of Glycemic Control in Diabetic Dialysis Patients – a Single Centre Prospective Observational Study Using Continuous Glucose Monitoring | Siddharth Sharma
Case Reports
210 | Belatacept Post Renal Transplantation in Patients with Contraindications to Calcineurin Inhibitors | David Langsford
211 | Rhabdomyolysis in Renal Transplant Recipient on Statin Therapy Post In!uenza Vaccination | Swarna Shashi Bhaskara
212 | Aplastic Anaemia in a Kidney-Pancreas Transplant Recipient | Andrea Viecelli
213 | A Case of Adenovirus Nephropathy in a Renal Allograft | Amit Nigam
214 | Invasive Pneumococcal Disease Involving Sterno-Clavicular Joint Septic Arthritis and Osteomyelitis, in the Late Post-Renal Transplant Period | Sanela Redzepagic
215 | Resistant Hypertension with a Carotid Space Mass: Is It Paraganglioma? A Case Report | Shenaaz Mazid
216 | Localised Cystic Kidney Disease – Case Report and Analysis of Literature | Brendan Smyth
217 | One of Lowest Ever Potassium to Have Survived | Vikas Srivastava
218 | An Unusual Case of Dietary Induced Secondary Oxalosis | Andrew Marriott
219 | Atypical Haemolytic Uraemic Syndrome with a Novel Complement Factor H Mutation | Brendan Smyth
220 | Renal Limited Tma and Acute Interstitial Nephritis with Single Dose of Quinine | Jobert Angelo
221 | An Unusual Cause of Acute Interstitial Nephritis | Rumbidzai Dahwa
222 | Renal Thrombotic Microangiopathy | Mathini Jayaballa
223 | Myeloma Cells Causing Coronary Ossi�cation | Siddharth Sharma
224 | Lercanidipine induced Acute Interstitial Nephritis, Never Reported Before | Vikas Srivastava
225 | Hemophagocytosis Causing Acute Tubular Necrosis, a Case Report | Vikas Srivastava
226 | Renal Sclerosing Peritubular Nodule-How Rare Is It? | Sajan Thomas
227 | Atypical Hemolytic Syndrome and Posterior Reversible Encephalopathy Syndrome | Sajan Thomas
228 | Paraneoplastic ANCA Negative Pauci-Immune Crescentic Glomerulonephritis with Renal Limited Thrombotic Microangiopathy in a Patient with Metastatic Breast Cancer – A Case Report | Bibin George
21
229 | Di!use Alveolar Haemorrhage – Is it Lupus? Or is it CMV? | Amit Nigam
230 | A Case of Large IVC and Bilateral Renal Vein Thrombosis in an Adult with Membranous Nephropathy Presenting as a Left Testicular Varicocele | Harish Puttagunta
231 | ANCA Negative Pauci-Immune Crescentic Glomerulonephritis Following Two Episodes of Sepsis | Sundareswari Vilayur Adinaryanan
232 | Ovaries in Disguise: A Primary Granulosa Cell Tumour Mimics a Pheochromocytoma | Joel Cooper
233 | Successful Parathyroid Ethanol Injection Therapy For Persistant Secondary Hyperparathyroidism | Richard Baer
234 | Rhizobium Radiobacter Associated Peritonal Dialysis Peritonitis – A Case Report with Literature Review | Thulasi Jegatheesan
235 | A Case Series of Suspected Lercanidipine Induced Chyloperitoneum in a Peritoneal Dialysis Population | Khai Yang Ooi
236 | The First Case of Paracoccus Yeeii Species Infection in Australia Causing Peritonitis in an APD Patient | Dharmenaan Palamuthusingam
237 | A Gram-negative Rampage in a Fledgling PD Programme | Neil Robinson
238 | Successful Treatment of Myeloma Cast Nephropathy with the New High-Cuto! Ultra#ux EMIC2 Dialyser | Chenlei Li
239 | Hepatitis C Virus Infection During Haemodialysis on Vacation: A Series of 3 Cases | Rahul Sud
240 | A Case Report of Calciphylaxis: Sequential Calciphylaxis and Warfarin Induced Skin Necrosis | Zaw Thet
241 | 14 Years of Haemodialysis with Impossible Vascular Access: Translumbar Inferior Vena Cava Catheterisation as Salvage Therapy | Samantha Chua
242 | Renal Allograft and Bladder Malakoplakia in a Renal Transplant Recipient: a Clinical Dilemma | Angela Graves
243 | Cerebral Sinus Venous Thrombosis Temporally Associated with Combination Tacrolimus/Sirolimus Immunosuppression | Angela Graves
22
ANZSIN Interventional Meeting
Platinum Sponsor
Gold Sponsors
Silver Sponsors
Wednesday 11 September
14:00 – 17:00 Workshop
Plaza P8
Renal Denervation in action AVF examination skills and USS USS visualised IJ lines and tunnelling USS visualised Renal Biopsy PD catheter insertion Fistuloplasty/stenting Concurrent Vein Mapping and Fistula US targeted at Vascular access and Haemodialysis nurses
17:00 – 17:45 Annual General Meeting
Plaza P7
19:00 – 23:30 Dinner *
* Transfers to dinner departing Brisbane Convention & Exhibition Centre
Thursday 12 September
Arbour A2
08:20 – 08:30 Introduction/Welcome/Housekeeping Richard Baer
08:30 – 10:30 Session One Chair: Steve May
08:30 – 09:00 PD Access – The Best Approach Miguel Riella
09:00 – 09:15 Management of malfunctioning PD Catheters Steve May
09:15 – 9:30 Transjugular Renal Biopsies Kendal Redmond
09:30 – 9:50 Tunnelled catheter removal/Stuck Permacaths Michael Lam – Case Kendal Redmond – Discussion
09:50 – 10:20 Update on Treatments for Resistant Hypertension, featuring Renal Denervation
George Mangos
10:20 – 10:30 Discussion All Above
10:30 – 11:00 Morning Tea
11:00 – 12:30 Session Two Chair: Richard Baer
11:00 – 11:20 Fistula Anatomy Mark Ray
11:20 – 11:35 Cannulation techniques Dianne Du Toit
11:35 – 11:50 Angioplasty inventory – The old and the new Murty Mantha
23
11:50 – 12:05 Guide Wire Issues Kendal Redmond
12:05 – 12:20 Mega!stula Steve May
12:20 – 12:30 Discussion All above
12:30 – 13:30 Lunch
13:30 – 15:00 Session Three Chair: John Saunders
13:30 – 13:55 Learning how to teach skills: theory and practice Rob Boots
13:55 – 14:10 eModule (Biopsy/Ytec PD Catheter) info session John Saunders
14:10 – 14:30 USS Visualisation for central venous dialysis catheters Tim Spicer
14:30 – 14:50 ASDIN International Trainer Certi!cation David Voss
14:50 – 15:00 Discussion All above
15:00 – 15:30 Afternoon Tea
15:30 – 17:30 Session Four Chair: David Voss
15:30 – 16:00 Vascular Access: Strengthening the Achilles Heel Miguel Riella
16:00 – 16:20 Panel Q&A: Procedure registries and State of Interventional Nephrology: ANZ
Steve May, Murty Mantha, Sajiv Cherian, Dianne Du Toit, John Saunders, Richard Baer
16:20 – 16:45 State of Interventional Nephrology: International Miguel Riella
16:45 – 17:00 Panel Discussion All Above
17:00 – 17:30 Poster Session
Dinner
Ultrasound for Nephrologists CourseArbour A1 & A2
Friday 13 September
08:00 – 08:30 Registration & Welcome Breakfast Co!ee
08:30 – 10:00 Basics: Ultrasound Physics and Machines
Errors and Artefacts
Normal Renal Ultrasound
10:00 – 10:15 Morning Tea
10:15 – 11:15 Renal Pathology: 1 & 2
11:15 – 13:00 Hands On: Normal Kidneys and Pathology
13:00 – 14:00 Lunch/Displays
14:00 – 15:00 Renal biopsy & Introduction to AV !stula scanning
15:00 – 16:30 Hands On: AVF, Renal biopsy
16:30 – 17:00 Conclusion